Supplementary Table 2 from IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy

XLSX file - 33K, Supplementary table 2: Overlapping pathways and differentially expressed genes (2 fold change, P<.05, Benjamini Hochberg adjusted) in H526 xenografts according to the treatment conditions: R1507 day 1,R1507 day 7, R1507-CDDP day 7 and R1507-IR day 7. The overlap significance (P value) between the differentially expressed probe sets and the curated molecular signature databases were computed using Fisher exact tests.